<DOC>
	<DOCNO>NCT01586455</DOCNO>
	<brief_summary>The purpose clinical trial investigate safety human placental-derived stem cell ( HPDSC ) give conjunction umbilical cord blood ( UCB ) stem cell patient various malignant nonmalignant disorder require stem cell transplant . Patients get either full dose ( high-intensity ) low dose ( low intensity ) chemo- immunotherapy follow stem cell transplantation UCB HPDSC .</brief_summary>
	<brief_title>Human Placental-Derived Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Gaucher Disease</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Adrenoleukodystrophy</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Anemia , Diamond-Blackfan</mesh_term>
	<mesh_term>Wolman Disease</mesh_term>
	<mesh_term>Leukodystrophy , Metachromatic</mesh_term>
	<mesh_term>Niemann-Pick Diseases</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type A</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type C</mesh_term>
	<mesh_term>Mucopolysaccharidosis I</mesh_term>
	<mesh_term>Neuronal Ceroid-Lipofuscinoses</mesh_term>
	<mesh_term>Leukodystrophy , Globoid Cell</mesh_term>
	<mesh_term>Mucopolysaccharidosis VI</mesh_term>
	<mesh_term>Fucosidosis</mesh_term>
	<criteria>&lt; 55 year age Life expectancy great 3 month Lansky performance status ≥ 50 % ( child ) Karnofsky performance status ≥ 70 % ( adult ) ECOG performance status 02 ( adult ) DLCO &gt; 50 percent predict Left ventricular ejection fraction &gt; 40 % estimate Creatinine clearance estimate GFR . 60 mL/min/1.73m2 Serum bilirubin &lt; 1.5x upper limit normal Transaminases &lt; 3x upper limit normal Absence uncontrolled infection HIV negative Fanconi Anemia Myocardial infarction within 6 month prior enrollment New York Heart Association ( NYHA ) Class III IV heart failure , uncontrolled angina , severe uncontrolled ventricular arrhythmia , electrocardiographic evidence acute ischemia active conduction system abnormality Uncontrolled infection Pregnant breastfeeding female Received investigational agent within 30 day prior start condition regimen</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>umbilical cord blood</keyword>
	<keyword>stem cell transplantation</keyword>
	<keyword>placental stem cell</keyword>
	<keyword>inborn error metabolism</keyword>
	<keyword>marrow failure</keyword>
	<keyword>Severe Combined Immunodeficiency Disease</keyword>
	<keyword>AML</keyword>
	<keyword>ALL</keyword>
	<keyword>MDS</keyword>
</DOC>